The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Compliance concerns may be driven largely by the desire to say out of the regulatory spotlight, but it’s also a business strategy, a panel of experts told an audience during this week’s MassDevice.com Big 100 West event in Orange County, Calif.
Photograph by Carolyn Bick
Nearly 300 of the industry’s best and brightest gathered for a night of big ideas, industry insights and few cocktails last night at MassDevice.com’s Big 100 East 2013 conference in Waltham, Mass.
By Rachael Garrison
The Centers for Medicare and Medicaid Services (CMS) is continuing its efforts to quickly implement the Transparency Reports and Reporting of Physician Ownership or Investment Interests section of the Patient Protection and Affordable Care Act, commonly referred to as the "Sunshine Act."
By James Squier
By Danielle Burke
On November 27, 2012, the Office of Management and Budget (OMB) received final regulations from the Centers for Medicare and Medicaid Services (CMS), which would implement the "Transparency Reports and Reporting of Physician Ownership or Investment Interests" section of the Patient Protection and Affordable Care Act. CMS previously missed the October 1, 2011, deadline to establish regulations implementing this section, which is commonly referred to as the "Sunshine Act." The text of the final regulations is not currently available for viewing.
Last week, the Massachusetts Senate and House of Representatives both passed House Bill 4200. Currently, Massachusetts’s Pharmaceutical and Medical Device Manufacturer Conduct Law, requires the Department of Public Health to “adopt a standard marketing code of conduct for all pharmaceutical or medical device manufacturing companies that employ a person to sell or market prescription drugs or medical devices in the commonwealth.”
by Hiramella Deonarine and Ingrid Pelzer
Pursuant to Vermont’s Prescribed Products Gift Ban and Disclosure Law (Law), manufacturers of prescription drugs, biological products and medical devices are required to disclose to the Vermont Attorney General’s Office (AG’s Office) the value, nature, purpose, and recipient of any allowable expenditure or permitted gift.
by Ingrid A. Pelzer
by Ingrid A. Pelzer
In December 2011, the Centers for Medicare and Medicaid Services published draft regulations that would implement the "Transparency Reports and Reporting of Physician Ownership or Investment Interests" section of the Patient Protection and Affordable Care Act, commonly referred to as the Sunshine Act.
by Ingrid A. Pelzer
The Massachusetts House of Representatives recently voted on and passed its proposals for the commonwealth’s Fiscal Year 2013 budget. The proposal included Consolidated Amendment I, which would repeal the Pharmaceutical and Medical Device Manufacturer Conduct Law [Mass. Gen. Laws Ch. 111N].
